On Jan 24, 2023, England became the only high-income country in which a national cancer control plan (NCCP)—in place since September, 2000—was not a central pillar of national health policy. This policy is at odds with all other devolved nations of the UK.1 Instead, the then Secretary of State for Health, the Rt Hon Steven Barclay, announced that cancer would be subsumed into a Major Conditions Strategy (MCS). Despite the sparseness of details about the MCS, a year on we critically examine what this policy means for cancer care delivery in the National Health Service in England (hereafter referred to as the NHS).